HAVCR2 can also serve as an LSC-specific target (Figures 11–12); this finding is similar to that in a recent AML publication (Kikushige and Akashi, 2012; Kikushige et al., 2015). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.